Sellas Announces U.S. FDA Rare Pediatric Disease Designation (Rpdd) Granted to Sls009 for the Treatment of Pediatric Acute Myeloid Leukemia
Sellas宣佈,Sls009獲得美國FDA頒發的罕見兒童疾病(Rpdd)資格,用於治療兒童急性髓性白血病。
Sellas Announces U.S. FDA Rare Pediatric Disease Designation (Rpdd) Granted to Sls009 for the Treatment of Pediatric Acute Myeloid Leukemia
Sellas宣佈,Sls009獲得美國FDA頒發的罕見兒童疾病(Rpdd)資格,用於治療兒童急性髓性白血病。
譯文內容由第三人軟體翻譯。